Cargando…
Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
Vaccine efficacy against SARS-CoV-2 could be compromised by the emergence of SARS-CoV-2 variants and it is important to study how it impacts the booster vaccination regime. We investigated the humoral and T cell responses longitudinally in vaccinated uninfected (n = 25) and post-COVID-19 individuals...
Autores principales: | Fu, Jolene Yin Ling, Pukhari, Muhammad Harith, Bador, Maria Kahar, Sam, I-Ching, Chan, Yoke Fun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146761/ https://www.ncbi.nlm.nih.gov/pubmed/37112825 http://dx.doi.org/10.3390/v15040844 |
Ejemplares similares
-
Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023) -
SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia
por: Chong, Yoong Min, et al.
Publicado: (2020) -
Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022) -
SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021
por: Fu, Jolene Yin Ling, et al.
Publicado: (2022) -
Chikungunya Virus in Macaques, Malaysia
por: Sam, I-Ching, et al.
Publicado: (2015)